• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

$1,995.00 – $3,990.00

Clear
SKU: KLI5309370 Categories: Clinical Chemistry, Diagnostics Market Research, Immunoassays, Lab Testing Services, Molecular & Nucleic Acid Testing, Point-of-Care Diagnostics Pages: 1200
  • Description
  • Table of Contents
  • Latest reports

Description

The in vitro diagnostics  (IVD) market attracts considerable interest.  There are hundreds of participating companies, competing in multiple areas of testing.  Each IVD segment could be said to function as an industry in and of itself.  There are companies who specialize in one area and companies who participate across segments.  There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies.  It’s often necessary for competitors to know about all of the segments of testing as different technologies can often compete.  This single volume Kalorama Information report has been written and updated for over a decade in nine editions, with the purpose of keeping readers informed about developments in clinical testing.  It covers the entirety of the clinical testing market, reports on hundreds of competitors, details deals and acquisitions and computes market size statistics for important segments.   Published every two years, this volume includes recent market size and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including
 
  • Clinical Chemistry and “Core Lab” Markets (including sub segment revenues for General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
  • Near-Patient and Point of Care Testing (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
  • Tissue-Based Testing – Histology and Cytology (Pap, ISH, IHC, HPV)
  • Microbiology Immunoassay Testing  (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
  • Hematology
  • Molecular Tests in Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others
  • Non-Infectious Disease Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
  • Coagulation Tests (Lab-Based, POC, Genetic Markers)
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
No other report provides an similar sense of the world diagnostics market.   Shara Rosen (MBA, RT)  has edited nine editions of this superior work intended to provide IVD market coverage in a world perspective.  A month’s long research effort creates authoritative market estimates and forecasted growth models for in vitro diagnostic (IVD) testing products throughout the world.
 
This is a global report.  The following IVD markets are included:
 
  • North America
  • Europe (with total IVD market sizes for EU countries)
  • Asia (China, Japan, India)
  • Latin America
  • Emerging Markets
  • Rest of World
 
 
Not Just “Who Did What?”  This Report Answers “What are the Reasons Behind the Results”
 
The report does just report on deals, events in the industry, laboratory trends and corporate results.  It provides that information, but it also analyzes why trends are occurring, and what readers can expect in the future.   
 

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an IVD industry veteran, who has tracked hundreds of companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the industry as it is in 2014. The report includes data in a sizeable number of IVD segments and detailed discussion of the trends that are impacting the industry. The report also provides a realistic forecast five years into the future for companies already participating in or considering entry into this growing industry.  Many top IVD companies have purchase this volume and use the data within for their business planning efforts. 

The same business intelligence top companies possess is available to purchasers of this unique report.

 
The report contains detailed profiles of the top players in IVD. Profiling in this report describes the developments in each significant division of their business. A number of secondary players are also extensively profiled, as well as specialty companies with expertise in one testing area.
  • Abbott Diagnostics
  • Alere Inc.
  • Arkray
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Ortho Clinical Diagnostics (OCD)
  • QIAGEN N.V.
  • Siemens Healthcare Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Affymetrix Inc.
  • Cepheid
  • Eiken Chemical Co., Ltd
  • ERBA Diagnostics, Inc.
  • DiaSorin S.p.A
  • Fujirebio Diagnostics, Inc.
  • Illumina
  • LabCorp
  • Luminex Corporation
  • Roche Diagnostics
  • Wako Pure Chemical Industries
And hundreds of other companies…
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data for the in vitro diagnostic market are presented in U.S. dollar market size for categories of tests, and for specific analytes where possible. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.
 
The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author’s industry knowledge combined with literature searches and interviews with industry professionals and experts in the IVD industry.

Table of Contents

One: Executive Summary

Introduction – Doing More with Less

Scope and Methodology

Size and Growth of the Market

Market Trends

Two: Introduction

Background

Report Design

Lab Medicine Disciplines and Applications

Market Analysis of IVD Market Segments

The Lure of IVD – Companies Mix and Match

Distribution Agreements

Licenses and Collaboration Agreements

Test Services

Top Suppliers and Niche Players

Selected Test Innovations from Non-Commercial Facilities

Baylor Research Institute, Dallas, TX

Boston University, Boston, MA

Brown University, Providence, RI

California Institute of Technology, Pasadena, CA

California NanoSystems Institute at the UCLA Henry Samueli School of Engineering and

Applied Science, Los Angeles, CA

Cedars Sinai Medical Center, Los Angeles, CA

Cleveland Clinic, Cleveland, OH

Duke University, Durham, NC

Hartford Hospital, Hartford, CT

Johns Hopkins University School of Medicine, Baltimore, MD

MedStar Washington Hospital Center, Washington, DC

Mount Sinai’s Samuel Lunenfeld Research Institute, Toronto, ON

Northeastern University, Boston, MA

Peking University, Beijing, China

Queensland Institute of Medical Research, Brisbane, Australia

Schneider Children’s Medical Center of Israel, Tel Aviv, Israel

Stockholm University, Sweden

Tokyo Medical and Dental University, Tokyo, Japan

University of British Columbia, Vancouver, BC

University of California, Davis, CA

University of California, Urvine, Urvine, CA

University of Cincinnati, Cincinnati, OH

University of Cologne, Cologne, Germany

University of Washington, Seattle, WA

Vanderbilt University, Nashville, TN

Weill Cornell Medical College, New York, NY

Yonsei University Health System, Seoul, S. Korea

Point of View

Three: Overview of Global In Vitro Diagnostic Markets

Background

Population and Disease Demographics, Worldwide

Emerging Markets as a Market Driver

World Segments of the IVD Market and IVD Market Evolution

Specific Country Information

The United States of America – a World in Flux

Japan

Europe: Negative Growth – Effects of Austerity

China

India

Brazil

Russia

Canada

Four: Trends and Innovation

Background

IT Enables Sample to Insight

Omics and BIG Data

Sequencing Moves to the Clinic

Personalized Precision Medicine Advances and Barriers

LOCs Enable Mobile Health (mHealth)

Five: Point-of-Care Tests

Overview

Professional POC

OTC Self Testing

Colon Cancer Screening

The Major POC Test Players

Diabetes Testing – Blood Glucose Monitoring

Glucose Market Shakeup

Diabetes Market Analysis

Blood Glucose Self-Testing

Continuous Self-Testing

Blood Glucose Testing by Professionals

New Technologies

Diabetes Testing – Glycated Hemoglobin

The Genetics of Diabetes

Six: The Core Lab

Core Lab Overview

Overview of Chemistry Tests

Lab Automation

Market Analysis

Lab-based Chemistries

Critical Care Analysis

User Apps

Urinalysis

The Commercial Outlook for Chemistry Tests

Seven: Immunoassays

Overview of Immunoassays

Immunoassay Technology Continues to Evolve

Immunoassays in the Core Lab

Special Topic – Metabolite Testing

Market Analysis

Leading Suppliers and Growth Potential

Mature Assay Segment

Thyroid Function

Therapeutic Drug Tests

Anemia

Toxicology/DAU

Allergy

Maturing Immunoassays

Proteins

Growth Immunoassays

Vitamin D

Tumor Markers

Cardiac Markers

Autoimmune

Diabetes

Transplant Management

Women’s Health

Gastrointestinal Disorders

Miscellaneous

Point-of-Care OTC and Professional Use

Patient Self-Tests (OTC)

Pregnancy Testing

Cardiovascular Diagnostics

Drugs of Abuse/Therapeutic Drug Monitoring

The Commercial Outlook for Immunoassays

Eight: Molecular Assays

Overview

Advanced Molecular Tests and Technologies

Digital PCR

Exomes

Major Players

Market Analysis

Oncology

Inherited Diseases

Prenatal Analysis

Tissue Typing

The Commercial Outlook for Molecular Tests

Nine: Hematology

Overview of Hematology

Digital Image Analysis

Digital Evolution

Decentralized Hematology Testing

Hemoglobin/Hematocrit at the POC

Market Analysis: Leading Suppliers

The Commercial Outlook for Hematology Tests

Ten: Coagulation

Overview of Coagulation and Immunohematology Tests

Genetics and Personalized Medicine

Warfarin

Plavix

Market Analysis

Lab-based Testing

Genetic Markers of Hypercoagulopathies

Decentralized Coagulation Testing – Professional Use

Decentralized Coagulation Testing – OTC

Platelet Testing

Leading Suppliers

The Commercial Market for Coagulation Tests

Eleven: Microbiology and Virology

Overview

Special Topics

Some Disease Facts

Emerging Disease Threats

Antimicrobial Drug Resistance

Mass Spectrometry Not a Pipedream

Sepsis Serology

Market Analysis

Supplies

Microbial Identification and Antimicrobial Sensitivity Tests

Blood Culture

Rapid Tests

Immunoassays – Lab-based

Immunoassays – Rapid

Molecular Tests

The Commercial Outlook for Microbiology / Virology Tests

Twelve: Blood Banking Services

Overview

Blood Banking Gets a Shakeup

Blood Management – Are All These Transfusions Good Medicine?

Pathogen Alerts

Platelet Safety

Market Analysis

Blood Grouping and Typing

Immunoassays

Nucleic Acid Testing (NAT)

The Commercial Outlook for Blood Banking

Thirteen: Histology and Cytology

Overview

Special Topics

Advanced Analysis Solutions

HPV Goes Core Lab

Market Analysis

Histology/Cytology

Immunohistochemistry and In Situ Hybridization

Pharmacodiagnostic Histology

Digital Imaging

Circulating Tumor Cells

Flow Cytometry

The Commercial Outlook for Histology and Cytology Tests

Fourteen: Company Profiles: The Top Tier

Abbott Diagnostics

Recent Revenue History

2013 Highlights

Core Lab

Immunoassays

Molecular

Hematology

Histology

Blood Bank

Point of Care

Diabetes

IntelligentMDx Alliance

PLEX-ID

Alere Inc.

Recent Revenue History

HIV

Lab-based

Blood Gases

Hematology

Microbiology

Toxicology

Cardiology

Mail Order Glucose Meters

Molecular

Alere Medical India

Arkray

Recent Revenue History

Molecular

Beckman Coulter, Inc. / Danaher

Recent Revenue History

Core Lab

Hematology

Immunoassays

Histology

Flow Cytometry

Molecular

Lab Services

Becton, Dickinson and Company (BD)

Recent Revenue History

Initiatives

Traditional Microbiology

Blood Culture

The BD MAX Enterprise

HPV

Veritor System – Immunoassays

Continuous Blood Glucose

Flow Cytometry

Histology

Mass Spectrometry

bioMérieux Inc.

Recent Revenue History

Expansion

Immunoassays

Blood Culture

Molecular Strategy

Mass Spectrometry

Bio-Rad Laboratories, Inc.

Recent Revenue History

Controls

Digital PCR

Blood Bank

Flow Cytometry

Lab Automation

Danaher Corporation

Recent Revenue History

Hologic, Inc.

Recent Revenue History

Product News

Blood Bank

Quest Contract

The Gen-Probe Business

Panther System

Instrumentation Laboratory (IL)

Recent Revenue History

New Products

Direct Sales

Ortho Clinical Diagnostics (OCD)

Recent Revenue History

Blood Bank

QIAGEN N.V.

Recent Revenue History

Personalized Healthcare

TB Testing

HPV

Oncology

Automation for the Future

Rotor-Gene Q

Exosomes

Sequencing

Information Technology

Point of Care

Collaborations

Radiometer A/S

Recent Revenue History

Immunoassays

Hemocue AB

Roche Diagnostics

Recent Revenue History

Reorganization

The PCR Enterprise

Core Lab

Molecular Core Lab IT

Immunoassays

Diabetes

Point of Care

Coagulation

HPV

Blood Bank

Liquid Biopsy

Molecular

Sequencing

Siemens Healthcare Diagnostics

Core Lab

Immunoassays

Hematology

Microbiology

Point of Care

Coagulation

Histology

Urinalysis

Critical Care

Molecular

Companion Diagnostics

Sequencing

Sysmex Corporation

Recent Revenue History

Hematology

Coagulation

Clinical Chemistry

Inostics GmbH

Intraoperative Test

Flow Cytometry

Thermo Fisher Scientific Inc.

Recent Revenue History

Sepsis

Histology

Allergy

Therapeutic Drug Monitoring

Mass Spectrometry

Microbiology

Werfen Group S.A

Fifteen: Company Profiles: The Second Tier

Affymetrix Inc.

Recent Revenue History

Agilent Technologies

Recent Revenue History

Arrays

Sample Management

Mass Spectrometry

Expansion

Cepheid

Recent Revenue History

Hospital Acquired Infections (HAI)

TB

Infectious Diseases

Oncology

Eiken Chemical Co., Ltd

Recent Revenue History

ERBA Diagnostics, Inc.

Recent Revenue History

ERBA Mannheim

DiaSorin S.p.A.

Recent Revenue History

Molecular

Immunoassays

Fujirebio Diagnostics, Inc.

Recent Revenue History

Molecular

Illumina

Recent Revenue History

Sequencing

Cytogenetics

Prenatal Testing

CLIA Lab Service

Nanopore Sequencing

Sample to Insight

IP Situation

LabCorp, Laboratory Corporation of America

Recent Revenue History

Collaborations

BRCA Saga

Life Technologies Corporation

Recent Revenue History

Life Technologies as an IVD Company

Partnerships Worldwide

Life and Quidel Develop Diagnostics on the 7500 Fast Dx

Sepsis

HIV

Emerging Pathogens

Bacterial Typing

Personalized Medicine

Instrumentation and Applications

Luminex Corporation

Recent Revenue History

Business Expansion

MAGPIX Multiplexing

Next Generation NxTag

Product News

Menarini Diagnostics

Recent Revenue History

Myriad Genetics

Recent Revenue History

Product News

The U.S. Market

IP Update

PerkinElmer, Inc. (PE)

Recent Revenue History

Newborn Testing

Prenatal Testing

Histology

Sequencing

Mass Spectrometry

Information Technology

China

Quest Diagnostics

Recent Revenue History

Quidel Corporation

Recent Revenue History

Acquisitions

Point of Care

Immunoassays

Molecular

Savanna (formerly Wildcat)

Randox Laboratories Ltd.

Recent Revenue History

Controls

Immunoassays

Molecular

TOSOH Corporation

Recent Revenue History

Immunoassays

Transasia Bio-Medicals Ltd.

Recent Revenue History

Trinity Biotech plc

Recent Revenue History

Product News

Wako Pure Chemical Industries, Ltd.

Recent Revenue History

Sixteen: Company Profiles: Blood Bank Specialists

Cerus Corporation

Recent Revenue History

Grifols

Recent Revenue History

Haemonetics Corporation

Recent Revenue History

Immucor, Inc.

Recent Revenue History

Immunetics Inc.

Recent Revenue History

Novartis Molecular Diagnostics

Recent Revenue History

International Programs

Quotient Limited

Recent Revenue History

Terumo BCT

Recent Revenue History

Verax Biomedical Inc.

Recent Revenue History

Seventeen: Company Profiles: Coagulation Specialists

Accriva Diagnostics

Recent Revenue History

A Bit of History

Atherotech Diagnostics Lab

Recent Revenue History

Diagnostica Stago, S.A.S.

Recent Revenue History

Gamma Therapeutics, Inc.

Microvisk Technologies

Eighteen: Company Profiles: Core Lab and Other Companies

77 Elektronika Kft

AB SCIEX Pte Ltd.

Recent Revenue History

Danaher Combines Two Forces

Bruker BioSciences Corporation

Recent Revenue History

Microbiology

Menu Expansion

NMR

Diatron MI Plc

Recent Revenue History

EliTech Group S.A.S.

Recent Revenue History

IRIS International, Inc.

Recent Revenue History

Medica Corporation

Recent Revenue History

MedTest DX

Recent Revenue History

Mindray Medical International Limited

Recent Revenue History

Nova Biomedical

Recent Revenue History

Diabetes

Nineteen: Company Profiles: CTC Test Providers

Abnova

AdnaGen AG

Angle plc

ApoCell, Inc.

Biocept, Inc.

Recent Revenue History

Clearbridge BioMedics

Cynvenio Biosystems, Inc.

Epic Sciences Inc.

Fluxion Biosciences, Inc.

Recent Revenue History

Icellate AB

ProKyma Technologies

RareCyte, Inc.

ScreenCell

Veridex, LLC

Recent Revenue History

WaveSense LLC

Twenty: Company Profiles: Diabetes Specialists

AgaMatrix, Inc.

Recent Revenue History

ALR Technologies Inc.

Animas Corporation

Recent Revenue History

Bayer Diabetes Care

Recent Revenue History

DexCom, Inc.

Recent Revenue History

Echo Therapeutics, Inc.

Recent Revenue History

Entra Health Systems

Recent Revenue History

iHealth Lab Inc.

Infopia Co Ltd

Recent Revenue History

Insulet Corporation

Recent Revenue History

U.S. Medicare Effects

Integrity Applications Inc.

Recent Revenue History

LabStyle Innovations Corp

Lifescan Inc.

Recent Revenue History

IP Issues

Medtronic Inc.

Recent Revenue History

Service Expansion

Newomics Inc.

Recent Revenue History

Prodigy Diabetes Care, LLC

Recent Revenue History

Sanofi Diabetes

Recent Revenue History

Senseonics, Incorporated

Recent Revenue History

Tandem Diabetes Care, Inc.

Recent Revenue History

TelCare Inc.

Recent Revenue History

Twenty-One: Company Profiles: Hematology (Cell Analysis) Specialists

CellaVision AB

Recent Revenue History

Constitution Medical, Inc.

DVS Sciences, Inc.

Horiba Medical

Recent Revenue History

OrSense Ltd.

Partec GmbH

Recent Revenue History

Twenty-Two: Company Profiles: Histopathology Specialists

Advanced Cell Diagnostics (ACD)

Recent Revenue History

Amoy Diagnostics Co. Ltd.

Applied Spectral Imaging Inc. (ASI)

Biocare Medical, LLC

Recent Revenue History

Biodis Biotechnology

BioMarker Strategies

BioView Ltd.

Recent Revenue History

Dako A/S

Recent Revenue History

Companion Diagnostics

Digital Imaging

Flow Cytometry

Automation

Alliances

Definiens

Recent Revenue History

DxTerity Diagnostics Inc.

Recent Revenue History

Leica Biosystems

Norchip

Ventana Medical Systems Inc.

Recent Revenue History

Digital Pathology

Virtuoso Software Update

Product News

Automation

China

Partnerships

Twenty-Three: Company Profiles: Immunoassay Specialists

ALPCO Diagnostics

Recent Revenue History

BG Medicine, Inc.

Recent Revenue History

Biohit Oyj

Recent Revenue History

Market Expansion

Corgenix Medical Corporation

Recent Revenue History

Systems

Tests

Critical Diagnostics

Diazyme Laboratories

Recent Revenue History

Euro Diagnostica AB

Recent Revenue History

Market Expansion

Genalyte Inc.

Recent Revenue History

Gold Standard Diagnostics

INOVA Diagnostics, Inc.

Recent Revenue History

Matrix-Bio Inc.

Oasis Diagnostics Corporation

OPKO Diagnostics

Recent Revenue History

Pronota NV

Quanterix Corporation

Tests in Development

Response Biomedical Corp.

Recent Revenue History

Sera Prognostics, Inc.

Twenty-Four: Company Profiles: Information Technology Specialists

Cartagenia

Cerner Corp.

CLC bio

Recent Revenue History

CollabRx Inc.

ConnectedHealth Pte. Ltd.

IBM Healthcare

Intel Corporation

Kaiser Permanente

MediSapiens Ltd.

Personalis Inc.

Twenty-Five: Company Profiles: Microbiology Specialists

AdvanDx, Inc.

Recent Revenue History

Co-Diagnostics HBDC

Copan Diagnostics Inc.

Recent Revenue History

Curetis AG

DxNA, LLC

Enigma Diagnostics Limited

Epistem Holdings plc

Focus Diagnostics, Inc.

Recent Revenue History

Great Basin Scientific, Inc.

Hain Lifescience GmbH

Recent Revenue History

Hutman Diagnostics AG

Recent Revenue History

Immunexpress Group

InBios International, Inc.

Intelligent Medical Devices, Inc. (IMDx)

Recent Revenue History

Laboratorios CONDA

Liofilchem s.r.l.

Recent Revenue History

Lophius Biosciences GmbH

Lumora

MAST GROUP Ltd.

ID/AST

Immunoassays

Molecular

MBio Diagnostics, Inc

Meridian Bioscience, Inc.

Recent Revenue History

Immunoassays

illumigene Molecular

Meridian Life Science

Miacom Diagnostics GmbH

Mobidiag Ltd

Nanosphere, Inc.

Recent Revenue History

Market Expansion

Pathogenica

Seegene, Inc.

Recent Revenue History

Instrumentation

Collaborations

Specific Technologies

Twenty-Six: Company Profiles: Molecular Test Specialists

Amoy Diagnostics Co. Ltd.

Recent Revenue History

Asuragen Inc.

Recent Revenue History

Controls

Sample Collection

Sequencing

BGI

Recent Revenue History

BGI Projects

Biocartis SA

Connectivity

Instrumentation

Collaborations

Idylla News

Biofortuna Ltd.

DiaCarta Inc.

Enzo Biochem Inc.

Recent Revenue History

IP Situation

Epigenomics

Recent Revenue History

Exosome Diagnostics

Genia Technologies Inc.

GenMark Diagnostics

Recent Revenue History

HTG Molecular Diagnostics

Recent Revenue History

IncellDx, Inc.

Recent Revenue History

Inform Genomics

Nanostring Technologies, Inc.

Recent Revenue History

QuantuMDx Group Limited

RainDance Technologies, Inc.

Recent Revenue History

Collaborations

Selventa

TessArae, LLC

Recent Revenue History

TrovaGene, Inc.

Recent Revenue History

Twenty-Seven: Company Profiles: Point of Care Test Specialists

1st Health Products Ltd.,

Abaxis, Inc.

Recent Revenue History

Aerocrine AB

Arbor Vita Corporation

Atomo Diagnostics

bioLytical Laboratories

Recent Revenue History

Chembio Diagnostic Systems, Inc.

Recent Revenue History

In Brazil

Counsyl Consumer

Recent Revenue History

DiAssess Inc

EKF Diagnostics Holdings Plc

Recent Revenue History

Molecular

Gentle Laboratories

GlysBy s.n.c.

IntraMed Diagnostics, LLC

LeucoDx

Luoxis Diagnostics Inc.

Maxim Biomedical, Inc.

MedMira Inc.

Recent Revenue History

Mode Diagnostics, Ltd

Recent Revenue History

NEC Corporation

OraSure Technologies, Inc.

Recent Revenue History

Pixie Scientific

Radisens Diagnostics Ltd.

Samsung Healthcare

STDcheck.com

Recent Revenue History

UDoTest

Twenty-Eight: Company Profiles: Prenatal Test Service Providers

Ariosa Diagnostics, Inc.

Recent Revenue History

IP Status

Berry Genomics Co. Ltd

CellScape Corporation

Recent Revenue History

GenePeeks, Inc.

Genomed AG

Good Start Genetics, Inc.

Illumina

Recent Revenue History

INEX (Innovations Exchange Pte Ltd)

Kellbenx Inc.

Natera

Recent Revenue History

NIPD Genetics Ltd

Sequenom Inc.

Recent Revenue History

Market Expansion

Coagulation

IP Issues

Sera Prognostics, Inc.

Twenty-Nine: Company Profiles: Test Service Providers

23andMe

Recent Revenue History

Adaptive Biotechnologies Corporation

Agendia BV

Recent Revenue History

Ambry Genetics

Recent Revenue History

ARUP Laboratories

Recent Revenue History

Assurex Health

Recent Revenue History

Athena Diagnostics

Recent Revenue History

BioReference Laboratories, Inc. (BRLI)

Recent Revenue History

Boulder Diagnostics Inc.

Cancer Genetics, Inc. (CGI)

Recent Revenue History

CardioDx, Inc.

Clarient Diagnostic Services, Inc.

Recent Revenue History

Combimatrix Corp

Recent Revenue History

Diatherix Laboratories Inc.

Genomic Health, Inc.

Recent Revenue History

Market Uptake

Sequencing

Imugen Inc.

Lab21 Limited

Recent Revenue History

LipoScience Inc.

Recent Revenue History

Mayo Medical Laboratories

Information Technology

MDxHealth SA

Recent Revenue History

Medical Diagnostic Laboratories L.L.C. (MDL)

Metabolistics Inc.

Metabolon, Inc.

Metamark Genetics Inc.

OncoPlexDx

Rosetta Genomics Ltd.

Recent Revenue History

Sengenics International Pte Ltd

Veracyte, Inc.

Recent Revenue History

 

    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025
    February 14, 2025
    In Vitro Diagnostics Business Outlook, 2024 (6 updates)
    December 20, 2024
    The Worldwide Market for Clinical Laboratory Services, 9th Edition
    June 26, 2024

Related products

  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Companion Diagnostics Markets: Forecasts to 2018 (Cancer, Cardiovascular and...Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based...
Scroll to top